Crossmark

CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases

Crossref DOI link: https://doi.org/10.1007/s12033-021-00345-4

Published Online: 2021-05-31

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rasoulinejad, Seyed Ahmad https://orcid.org/0000-0002-0699-3010
Maroufi, Faezeh https://orcid.org/0000-0003-1368-8636
License Information

Text and Data Mining valid from 2021-05-31

Version of Record valid from 2021-05-31
More Information

Article History

Received: 8 June 2020

Accepted: 19 May 2021

First Online: 31 May 2021

Disclosures

:

: The authors declare that they have no conflict of interest.